IMUX · Immunic Inc
United States · RS rating 49 · As of 2026-10-14
| Price | 6.66 USD |
|---|---|
| 1-day change | -3.3% |
| RS rating (overall / 1M / 3M / 12M) | 49 / 4 / 4 / 99 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 29 / 41 / 49 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +25.9% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +60.6% |
| Market cap (USD) | $125.1M |